MedPath
HSA Approval

APO-GLICLAZIDE TABLET 80MG

SIN13468P

APO-GLICLAZIDE TABLET 80MG

APO-GLICLAZIDE TABLET 80MG

May 15, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BB09

gliclazide

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC.(150 SIGNET)

Active Ingredients

GLICLAZIDE

80 mg

Gliclazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.